期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CD38在慢性B淋巴细胞白血病细胞上表达的临床意义

Clinical Significance of CD38 Expression in Chronic B Lymphocytic Leukemia
下载PDF
导出
摘要 为探讨CD38在慢性B淋巴细胞白血病(B-CLL)细胞上表达的临床意义,用流式细胞仪检测了78例慢性B淋巴细胞白血病细胞上CD38的表达。结果显示,CD38的表达与患者年龄、骨髓中白血病细胞比例、外周血白细胞数目、血红蛋白含量、血小板数和脾肿大无关(P>0.05),而与Binet分期(C期)、外周血白血病细胞比例、淋巴结肿大和肝肿大有关(P值分别为0.017、0.037、0.039、0.038),并有明显缩短的生存期(P=0.032)。结论:CD38高表达是B-CLL患者预后差的一个可靠指标。 To explore the clinical significance of CD38 expression in chronic B lymphocytic leukemia （B-CLL） the expression of CD38 in 78 cases with B-CLL expressions in chronic B ripheral blood, overall survival. lymphocytic leukemia were analyzed by flow cytometry. The results showed that CD38 were significantly related with Binet stage, B-CLL cells in pelymphadenopathy and hepatomegaly. The patients with CD38 over-expression showed a shorter The CD38 expression could be as a poor prognostic indicator in B-CLL.
作者 张文艺 王冬侠 曹军 姜琪
机构地区 中国中医血液专病治疗中心河北廊坊市中医院临床检验中心
出处 《标记免疫分析与临床》 CAS 2009年第3期136-139,共4页 Labeled Immunoassays and Clinical Medicine
关键词 慢性B淋巴细胞白血病 CD38 流式细胞仪 预后 Chronic B lymphocytic leukemia CD38 Flow cytometry Prognosis
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Poeta G D,Maurillo L,Venditti A,et al.Clinical significance of CD38 expression in chronic lymphocytic leukemia[J].Blood,2001,98:2633-2639.
  • 2His E D,Kopecky K J,Appelbaum F R,et al.Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukemia[J].Br J Haematol,2003,120:1017-1025.
  • 3Chevallier P,Penther D,Avet-Loiseau H,et al.CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukemia[J].Br J Haematol,2002,116:142-150.
  • 4Boonstra J G,Van Lom K,Langerak A W,et al.CD38 as a prognostic factor in B cell chronic lymphocytic leukemia(B-CLL):Comparison of three approaches to analyze its expression[J].Cytometry B Clin Cytom,2006,70(3):136-141.
  • 5Montillo M,Hamblin T,Hallek M,et al.Chronic lymphocytic leukemia:novel prognostic factors and their relevance for risk-adapted therapeutic strategies[J].Haematologica,2005,90:391-399.
  • 6Willimott S,Baou M,Huf S,et al.Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4[J].Haematologica,2007,92(10):1359-1366.
  • 7Joshi A D,Heqde G V,Dickinson J D,et al.ATM,CTLA4,MNDA and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia[J].Clin Cancer Res,2007,13:5295-5304.
  • 8Deaglio S,Vaisitti T,Avdin S,et al.In-tandem insight from basic science combined with clinical research:CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia[J].Blood,2006,108(4):1135-1144.
  • 9Patten P E,Buggins A G,Richards J,et al.CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment[J].Blood,2008,111:5173-5181.
  • 10Pepper C,Ward R,Lin T T,et al.Highly purified CD38+ and CD38-sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin[J].Leukemia,2007,21(4):687-696.
标记免疫分析与临床
2009年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部